Search
Showing results for "1"
Research
Prevalence of celiac disease in 52,721 youth with type 1diabetes: International comparison across three continentsTim Jones MBBS DCH FRACP MD Co-head, Diabetes and Obesity Research Co-head, Diabetes and Obesity Research Areas of research expertise: Diabetes
Research
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIVTo evaluate the safety and immunogenicity of V114 [15-valent pneumococcal conjugate vaccine (PCV) containing serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9 V, 14, 18C, 19A, 19F, 22F, 23F, 33F], followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) 8 weeks later, in children with HIV.
Research
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEThe pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment response versus placebo in peanut-allergic toddlers aged 1 through 3 years.
Research
Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBADMitophagy preserves overall mitochondrial fitness by selectively targeting damaged mitochondria for degradation. The regulatory mechanisms that prevent PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin (PINK1/Parkin)-dependent mitophagy and other selective autophagy pathways from overreacting while ensuring swift progression once initiated are largely elusive.
Research
Resilience and Diabetes 2 (the RAD2 study)Investigators: Anna Hunt, Ashleigh Lin Stress and anxiety are significant problems in children and adolescence with type 1 diabetes. Not only do
News & Events
Teaching Kitchensthe Teaching Kitchens program will start again on Thursday March 9 from 5-7pm, running for four weeks (every thursday evening).
News & Events
Advanced hybrid closed loop in paediatric population technology studyOur researchers are looking for young children with type 1 diabetes who are using an insulin pump, to take part in the advanced hybrid closed loop in paediatric (HyCLIP) population study.
News & Events
Changes to the continuous glucose monitoring initiative from 1st March, 2022.The Dexcom G6 CGM system will be available through the NDSS to all our patients with Type 1 diabetes.
News & Events
Protein, exercise and hypo studyFor this study, we want to see how much protein is necessary to prevent overnight hypos without causing high blood glucose levels.
News & Events
Recruits needed for new tech studyMeet Sophie - she's Australia's first participant in the multi-site Advanced Hybrid Closed Loop study.